BCL10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.259350E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.583000E-01
Normal-vs-Stage2
5.190500E-04
Normal-vs-Stage3
8.561000E-01
Normal-vs-Stage4
8.875600E-02
Stage1-vs-Stage2
3.845400E-01
Stage1-vs-Stage3
6.827600E-01
Stage1-vs-Stage4
7.704200E-02
Stage2-vs-Stage3
2.710400E-01
Stage2-vs-Stage4
8.986100E-02
Stage3-vs-Stage4
8.375900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.235800E-03
Normal-vs-AfricanAmerican
3.649400E-01
Normal-vs-Asian
3.314300E-02
Caucasian-vs-AfricanAmerican
9.791800E-01
Caucasian-vs-Asian
1.690440E-01
AfricanAmerican-vs-Asian
3.401200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.580660E-03
Normal-vs-Female
4.967700E-04
Male-vs-Female
5.684400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.882000E-01
Normal-vs-Age(41-60Yrs)
4.35100000000244E-05
Normal-vs-Age(61-80Yrs)
3.623500E-03
Normal-vs-Age(81-100Yrs)
2.931800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.270200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.095000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.598800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.811900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.198100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.097400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.823770E-02
Normal-vs-Daily Drinker
3.849600E-02
Normal-vs-Weekly Drinker
1.479820E-01
Normal-vs-Occasional Drinker
1.210380E-01
Normal-vs-Social Drinker
5.066200E-01
Non Drinker-vs-Daily Drinker
6.470000E-01
Non Drinker-vs-Weekly Drinker
6.595600E-01
Non Drinker-vs-Occasional Drinker
6.451000E-01
Non Drinker-vs-Social Drinker
1.754020E-01
Daily Drinker-vs-Weekly Drinker
9.399000E-01
Daily Drinker-vs-Occasional Drinker
2.855800E-01
Daily Drinker-vs-Social Drinker
3.908600E-01
Weekly Drinker-vs-Occasional Drinker
3.241600E-01
Weekly Drinker-vs-Social Drinker
5.150800E-01
Occasional Drinker-vs-Social Drinker
3.844100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.122800E-01
Normal-vs-Grade 2
1.049450E-01
Normal-vs-Grade 3
4.942400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.102200E-03
Grade 1-vs-Grade 3
8.684800E-03
Grade 1-vs-Grade 4
4.122800E-01
Grade 2-vs-Grade 3
1.293580E-01
Grade 2-vs-Grade 4
1.049450E-01
Grade 3-vs-Grade 4
4.942400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.776200E-01
Normal-vs-NonDiabetic
4.643800E-04
Diabetic-vs-NonDiabetic
1.872810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.067900E-02
Normal-vs-NoPancreatitis
3.441800E-03
Pancreatitis-vs-NoPancreatitis
1.889000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.133970E-02
Normal-vs-N1
4.416500E-04
N0-vs-N1
3.081600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.918230E-01
Normal-vs-TP53-NonMutant
7.917000E-01
TP53-Mutant-vs-TP53-NonMutant
2.821800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
